<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Ugekommentar: Novo Nordisk er ikke færdig - tværtimod!]]></title><description><![CDATA[<p dir="auto">Efter Novos sammenligningsstudie af Carisema vs Tirzepatide har aktiekursen atter fået tæsk, og markedet virker til at have mistet troen på, at selskabet kan stå distancen på fedmemarkedet. Men Helge Larsen er stadig positiv på Novo Nordisk på den lange bane. Hør hvorfor i denne ugekommentar, hvor han kommer hele vejen rundt om alt fra pipelinen og konkurrencesituationen til fremtiden for selskabet. Hvordan ser Helge Larsen på 2026, 2027 og 2028?</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/UBlesHBdREY" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/395698/ugekommentar-novo-nordisk-er-ikke-frdig-tvrtimod</link><generator>RSS for Node</generator><lastBuildDate>Tue, 09 Jun 2026 05:18:08 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/395698.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 26 Feb 2026 14:47:51 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Mon, 09 Mar 2026 12:19:18 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk dropper søgsmål mod Hims &amp; Hers og bekræfter partnerskab<br />
<a href="https://proinvestor.com/investornyt/1419225/novo-nordisk-dropper-sogsmal-mod-hims-hers-og-bekraefter-partnerskab" rel="nofollow ugc">https://proinvestor.com/investornyt/1419225/novo-nordisk-dropper-sogsmal-mod-hims-hers-og-bekraefter-partnerskab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895930</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895930</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 09 Mar 2026 12:19:18 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 10:37:46 GMT]]></title><description><![CDATA[<p dir="auto">En meget glad aktionær i Hims.</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/QC4W6X-e3Qg" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895929</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895929</guid><dc:creator><![CDATA[B.Andersen]]></dc:creator><pubDate>Sat, 07 Mar 2026 10:37:46 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 09:18:10 GMT]]></title><description><![CDATA[<p dir="auto">Milito  Jeg synes ikke, at man skal samarbejde med en uhæderlig aktør. Men vestasfan  har nogle gode pointer. Lad os se, om den bliver bekræftet.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895934</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895934</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Sat, 07 Mar 2026 09:18:10 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 08:49:24 GMT]]></title><description><![CDATA[<p dir="auto">Hvorfor er det ikke en god nyhed?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895938</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895938</guid><dc:creator><![CDATA[Milito]]></dc:creator><pubDate>Sat, 07 Mar 2026 08:49:24 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 07:27:16 GMT]]></title><description><![CDATA[<p dir="auto">Helt og aldeles uenig. Et søgsmål kan trække ud i årevis og gør intet godt for nogen. Der er ingen tvivl om, at hvis aftalen er sand, har Hims givet sig og lagt sig fladt ned. De skal formentlig også kompensere Novo klækkeligt. Novo har overhånden, ikke Hims. Et meget positivt signal er det også, da de vidner om at apotekerne og online distributørene har forstået alvoren fra FDA.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895928</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895928</guid><dc:creator><![CDATA[vestasfan]]></dc:creator><pubDate>Sat, 07 Mar 2026 07:27:16 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 06:57:58 GMT]]></title><description><![CDATA[<p dir="auto">Puhaa, sikke en nyhed at vågne op til. Jeg håber et eller andet sted, at det ikke er sandt. Hvis det er sandt, så synes jeg ikke umiddelbart den nye CEO og bestyrelsesformand har specielt god dømmekraft.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895927</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895927</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Sat, 07 Mar 2026 06:57:58 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 06:37:58 GMT]]></title><description><![CDATA[<p dir="auto">For en god ordens skyld. Vi mangler at få en officiel bekræftelse på nyheden fra Novo og Hims.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895931</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895931</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Sat, 07 Mar 2026 06:37:58 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 06:27:43 GMT]]></title><description><![CDATA[<p dir="auto">En sådan aftale indgår Novo vel ikke uden en juridisk klokkeklar aftale aftale om at Hims stopper med comoundsalget af GLP1.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895950</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895950</guid><dc:creator><![CDATA[B.Andersen]]></dc:creator><pubDate>Sat, 07 Mar 2026 06:27:43 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sat, 07 Mar 2026 05:50:50 GMT]]></title><description><![CDATA[<p dir="auto">Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.reuters.com/business/healthcare-pharmaceuticals/novo-hims-resolve-dispute-will-sell-obesity-drugs-together-bloomberg-news-2026-03-07/">
reuters.com
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/novo-hims-resolve-dispute-will-sell-obesity-drugs-together-bloomberg-news-2026-03-07/" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.reuters.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.reuters.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895923</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895923</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Sat, 07 Mar 2026 05:50:50 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Mon, 02 Mar 2026 06:16:53 GMT]]></title><description><![CDATA[<p dir="auto">Tak BS, det er jeg glad for du syntes. <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=d361a5e1ce4" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895920</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895920</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 02 Mar 2026 06:16:53 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sun, 01 Mar 2026 06:39:04 GMT]]></title><description><![CDATA[<p dir="auto">Tak Helge for en nøgtern og saglig gennemgang med relevante vinkler, som mange investorer og finansmedier helt ser bort fra.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895919</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895919</guid><dc:creator><![CDATA[BSinvest]]></dc:creator><pubDate>Sun, 01 Mar 2026 06:39:04 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Sun, 01 Mar 2026 05:13:42 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk's financial health remains robust despite recent market challenges. The company reported a revenue of $47,399.42 million, with a three-year revenue growth rate of 21.3%. The company's profitability metrics are impressive, with an operating margin of 41.31% and a net margin of 33.14%. These figures indicate a strong ability to convert sales into profits.</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.gurufocus.com/news/8666145/novo-nordisk-nvo-faces-tough-month-amid-competitive-pressures">
Attention Required! | Cloudflare
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.gurufocus.com/news/8666145/novo-nordisk-nvo-faces-tough-month-amid-competitive-pressures" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.gurufocus.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.gurufocus.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895921</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895921</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sun, 01 Mar 2026 05:13:42 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Fri, 27 Feb 2026 21:04:06 GMT]]></title><description><![CDATA[<p dir="auto">Bag betalingsvæg. Samme argument, at Novo Nordisk måske har det bedste lægemiddel.</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://finans.dk/kommentar/ECE19054047/kan-novo-have-det-bedste-laegemiddel-uden-at-kunne-bevise-det/" title="Søren Linding: Kan Novo have det bedste lægemiddel uden at kunne bevise det?">
<img src="https://billeder.finans.dk/pictures/image/18205274/uuzmob/ALTERNATES/master-social/finans-profiler-5e-linding-png" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://finans.dk/kommentar/ECE19054047/kan-novo-have-det-bedste-laegemiddel-uden-at-kunne-bevise-det/">
Søren Linding: Kan Novo have det bedste lægemiddel uden at kunne bevise det?
</a>
</h5>
<p class="card-text line-clamp-3">De kliniske forsøgsdata siger et, men den danske medicinalkoncerns topledelse fastholder noget andet. Det er et stort spørgsmål, om Novo Nordisk kan nå at høste fordelene, hvis den får ret i, at den har den bedste vægttabsmedicin.</p>
</div>
<a href="https://finans.dk/kommentar/ECE19054047/kan-novo-have-det-bedste-laegemiddel-uden-at-kunne-bevise-det/" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://finans.dk/static/finans.dk/favicon/favicon-32x32.png" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>









<p class="d-inline-block text-truncate mb-0">Finans <span class="text-secondary">(finans.dk)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895922</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895922</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Fri, 27 Feb 2026 21:04:06 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Fri, 27 Feb 2026 19:59:13 GMT]]></title><description><![CDATA[<p dir="auto">23% vægttab! Er Novo Nordisks Cagrisema en fiasko?</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/ff0dV_8aGV0" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895916</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895916</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 27 Feb 2026 19:59:13 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Thu, 26 Feb 2026 18:17:21 GMT]]></title><description><![CDATA[<p dir="auto">Hej Helge, Reuben Gregg Brewer syntes som du, at Novo stadig er kongen indenfor diabetes <img
      src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=d361a5e1ce4"
      class="not-responsive emoji emoji-android emoji--slightly_smiling_face"
      style="height: 23px; width: auto; vertical-align: middle;"
      title=":-)"
      alt="🙂"
    /></p>
<p dir="auto">1 Reason Why I'd Hold This Weight‑Loss Drug Leader Through Any Market Crash</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://www.fool.com/investing/2026/02/25/1-reason-why-id-hold-this-weightloss-drug-leader/" title="1 Reason Why I'd Hold This Weight‑Loss Drug Leader Through Any Market Crash | The Motley Fool">
<img src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F854966%2F23_10_30-a-pharmacist-helping-a-customer-with-a-medicine-prescription-mf-dloadjpgcrdownload.jpg&w=1200&op=resize" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.fool.com/investing/2026/02/25/1-reason-why-id-hold-this-weightloss-drug-leader/">
1 Reason Why I'd Hold This Weight‑Loss Drug Leader Through Any Market Crash | The Motley Fool
</a>
</h5>
<p class="card-text line-clamp-3">Although pegged as a weight-loss stock, this drug maker's core business has long been diabetes.</p>
</div>
<a href="https://www.fool.com/investing/2026/02/25/1-reason-why-id-hold-this-weightloss-drug-leader/" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.fool.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0">The Motley Fool <span class="text-secondary">(www.fool.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895925</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895925</guid><dc:creator><![CDATA[Stroka]]></dc:creator><pubDate>Thu, 26 Feb 2026 18:17:21 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Thu, 26 Feb 2026 18:04:36 GMT]]></title><description><![CDATA[<p dir="auto">Hmm hjælp til meget syge mennesker bliver sammenlignet med en bobbel!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895915</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895915</guid><dc:creator><![CDATA[vestasfan]]></dc:creator><pubDate>Thu, 26 Feb 2026 18:04:36 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Thu, 26 Feb 2026 15:22:59 GMT]]></title><description><![CDATA[<p dir="auto">Og Ydermere, at Novo er interessant som udbytteaktie, jf. udbetaling og aktietilbagekøb..Så længe investorer smider Novo aktier i grøften.. glæder det mig langsigtet! Mine andre inv. genererer penge til yderligere køb... dog kortsigtet.. Make the math!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895917</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895917</guid><dc:creator><![CDATA[oneofakind]]></dc:creator><pubDate>Thu, 26 Feb 2026 15:22:59 GMT</pubDate></item><item><title><![CDATA[Reply to Ugekommentar: Novo Nordisk er ikke færdig - tværtimod! on Thu, 26 Feb 2026 15:17:22 GMT]]></title><description><![CDATA[<p dir="auto">Jeg tænker...Tulipaner!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/6895914</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/6895914</guid><dc:creator><![CDATA[oneofakind]]></dc:creator><pubDate>Thu, 26 Feb 2026 15:17:22 GMT</pubDate></item></channel></rss>